SCHEMBL21672255

SCHEMBL21672255

CC(C)c1cc(N)nc(C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
CRHBP P24387 1/20 0.43
CYP2C19 P33261 1/20 0.43
CRHR2 Q13324 1/20 0.43
CA2 P00918 1/20 0.38
CHKA P35790 1/20 0.38
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 1/20 0.38
NOS3 P29474 2/20 0.37
NOS1 P29475 2/20 0.37
NOS2 P35228 2/20 0.37
HSD17B10 Q99714 2/20 0.35
ALPL P05186 2/20 0.34
ALPI P09923 2/20 0.34
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29723070 0.87 HSP90AA1 (0.43) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR
SCHEMBL15241360 0.86 CYP2C19 (0.50) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR
SCHEMBL24027369 0.85 HSP90AA1 (0.42) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR
SCHEMBL10264859 0.79 NOS2 (0.48) KDM4EALDH1A1KMT2ANOS3NOS1
SCHEMBL18068097 0.78 CYP2C19 (0.58) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR
SCHEMBL15723315 0.78 CYP3A4 (0.44) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR
SCHEMBL19699451 0.78 HSP90AA1 (0.50) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR
SCHEMBL22767490 0.77 CYP2C19 (0.43) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR
SCHEMBL20738336 0.74 GAA (0.43) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR
SCHEMBL20642311 0.74 CYP3A4 (0.41) HSP90AA1HSP90AB1CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 US disclosed
US-20200039989-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200039989-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK1, CLK3 HSP90AA1 2552/4885HSP90AB1 2020/4885CYP3A4 4000/4885
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 HSP90AA1 4381/4885HSP90AB1 4125/4885CYP3A4 3080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.